VSee Health, Inc. cash flow to debt ratio of -141.43% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

VSee Health, Inc.'s free cash flow has increased -40.53% from $-5.84M last year to $-3.48M, signaling increasing performance

VSee Health, Inc.'s debt to equity ratio is 0.34, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

VSee Health, Inc.'s debt has increased relative to shareholder equity from -516.43 last year to 0.34 today, signaling weakened financials

VSee Health, Inc. has negative EBITDA, making leverage ratio unreliable

VSee Health, Inc.'s interest coverage ratio is -4.87, which means that the company struggles to meet interest obligations, signaling financial risk.

VSee Health, Inc.'s profit margin has increased (-83.32%) in the last year from -553.69% to -92.37%, signaling increasing performance

VSee Health, Inc.'s short-term liabilities of $16.24M exceed its short-term assets of $8.37M, signaling financial risk

VSee Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

VSee Health, Inc.'s return on equity of -11.57K%, is lower than 15.00%, indicating bad performance

VSee Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

VSee Health, Inc. had positive net income in only 1.00 out of 5 years, indicating unstable earnings

VSee Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

VSee Health, Inc. has negative free cash flow, indicating cash burn

VSee Health, Inc.'s yearly earnings has increased -74.50% since last year from $-57.70M to $-14.71M, signaling increasing performance

VSee Health, Inc.'s yearly revenue has increased 40.27% since last year from $10.42M to $14.62M, signaling increasing performance

ROIC -111.65% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

VSee Health, Inc.'s 3-year revenue CAGR of 31.85% is positive, indicating growing revenue over the past 3 years

VSee Health, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

VSee Health, Inc. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity

VSee Health, Inc. has insufficient data to evaluate this check.

VSee Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

VSee Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

VSee Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

VSee Health, Inc. is overvalued relative to its fair value price of -4.56 based on Earnings Fair Value model

VSee Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

VSee Health, Inc. has a price-to-book ratio of 0.75x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

VSee Health, Inc. has a price-to-sales ratio of 0.33x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue